Get the Stockscreener App
3.41
1.49%
0.05
Polypid Ltd stock is traded at $3.41, with a volume of 22,926.
It is up +1.49% in the last 24 hours and down -3.40% over the past month.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
See More
Previous Close:
$3.36
Open:
$3.37
24h Volume:
22,926
Relative Volume:
0.05
Market Cap:
$34.75M
Revenue:
-
Net Income/Loss:
$-23.87M
P/E Ratio:
-0.1734
EPS:
-19.67
Net Cash Flow:
$-47.63M
1W Performance:
-7.34%
1M Performance:
-3.40%
6M Performance:
+19.23%
1Y Performance:
-6.58%
1-Day Range:
$3.31
$3.4666
1-Week Range:
$3.31
$3.70
52-Week Range:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Compare PYPD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.41 | 34.24M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Initiated | Roth Capital | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Sep-14-21 | Initiated | JMP Securities | Mkt Outperform |
| Jul-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-10-20 | Initiated | Alliance Global Partners | Buy |
| Jul-21-20 | Initiated | BMO Capital Markets | Outperform |
| Jul-21-20 | Initiated | Barclays | Overweight |
| Jul-21-20 | Initiated | Raymond James | Outperform |
View All
Polypid Ltd Stock (PYPD) Latest News
What makes PolyPid Ltd. stock price move sharplyROI Focused Watchlist with Trade Confidence - Newser
What MACD and RSI say about PolyPid Ltd.Investment Timing Strategy with Market Filters - Newser
Full technical analysis of PolyPid Ltd. stockMachine Learning Stock Movement Detector - Newser
What is the risk reward ratio of investing in PolyPid Ltd. stockStock Strategy Picks For 2025 - jammulinksnews.com
Is PolyPid Ltd. stock entering bullish territorySafe Entry Strategy with High Win Rate - Newser
PolyPid to Report Q2 2025 Financial Results and Operational Highlights on August 13, 2025 - AInvest
Is PolyPid Ltd. a candidate for recovery playTrading Volume Anomaly Summary and Insight - Newser
How does PolyPid Ltd. generate profit in a changing economyTop Growth Ideas For 2025 - jammulinksnews.com
Regression analysis insights on PolyPid Ltd. performanceReal Time Alert System for Market Moves - Newser
How PolyPid Ltd. stock performs during market volatilityReal Time Growth Signal with Smart Setup - Newser
PolyPid Ltd. Company Revenue and Profit Trends: A Deep DiveLow Risk Stock Selection Strategy Guide - Newser
PolyPid Ltd. stock trend outlook and recovery pathStrong Buy Opportunity with Volume Support - Newser
PolyPid Ltd. Inches Toward Key Resistance — Will It BreakWeekly Watchlist of High Movers Released - metal.it
PolyPid Ltd. to Release Second Quarter 2025 Financial Results on August 13, 2025 - Quiver Quantitative
PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025 - GlobeNewswire
PolyPid Earnings: Biopharma Innovation Leader Sets Q2 2025 Financial Results Date - Stock Titan
Price Channel Expanding on PolyPid Ltd.’s ChartTrade Timing Strategy With Technical Data Explained - metal.it
PolyPid Ltd. stock retracement – recovery analysisPrice Action Trading with Volume Confirmation - Newser
Wyckoff Accumulation Phase Possible in PolyPid Ltd.Weekly Chart Analysis With Entry Advice Provided - metal.it
PolyPid Ltd. Flashes Rebound Signal in Oversold ConditionCapital Growth With Controlled Risk Picks Suggested - metal.it
How strong is PolyPid Ltd. company’s balance sheetRetirement Planning Insights With High Returns - jammulinksnews.com
Is it the right time to buy PolyPid Ltd. stockAchieve exceptional returns with expert guidance - jammulinksnews.com
Why is PolyPid Ltd. stock attracting strong analyst attentionExceptional stock performance - jammulinksnews.com
Will PolyPid Ltd. Stock Benefit from AI and Green Energy TrendsSwing Trade Entry and Exit Point Analysis - Newser
PolyPid Ltd. stock retracement – recovery analysis Capital Protection Strategy With Risk Analysis - Newser
Is PolyPid Ltd. a growth stock or a value stockExceptional growth trajectory - jammulinksnews.com
When is PolyPid Ltd. stock expected to show significant growthFinancial News Guidance For Beginners - jammulinksnews.com
What are analysts’ price targets for PolyPid Ltd. in the next 12 monthsDiscover breakthrough trading strategies - jammulinksnews.com
How Resilient Is PolyPid Ltd. Stock During Economic DownturnsTrend Based Entry Alerts - metal.it
What are PolyPid Ltd. company’s key revenue driversRemarkably fast returns - jammulinksnews.com
Does PolyPid Ltd. stock perform well during market downturnsHigh-yield portfolio picks - jammulinksnews.com
Is PolyPid Ltd. a Top Dividend Stock to Watch in 2025Smart Growth Low Risk Picks - Newser
Is PolyPid Ltd. a good long term investmentAccelerated profit realization - PrintWeekIndia
Is PolyPid Ltd. stock a good hedge against inflationFree Stock Selection - jammulinksnews.com
Will PolyPid Ltd. stock benefit from interest rate changesRapid wealth multiplication - jammulinksnews.com
Why PolyPid Ltd. stock attracts strong analyst attentionReal Trader Insights - Newser
Polypid Ltd Stock (PYPD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):